In a 1st, Seattle Children's to test CAR T-cell drug among children with lupus

Seattle Children’s is the first FDA-authorized site to deliver an experimental CAR T-cell therapy to children with lupus, the system said March 11. 

Read the full post on Becker's Hospital Review | Healthcare News & Analysis